Comparison of Two Dementia Care Interventions and Usual Care on Days Spent at Home: The D‐ CARE Randomized Clinical Trial

BACKGROUND: Days spent at home (DSAH) is a clinically meaningful patient-centered outcome among persons living with dementia (PLWD). OBJECTIVE: To evaluate whether either of two dementia care interventions increased the number of DSAH compared with each other and with usual care. DESIGN: Pragmatic 18-month 3-arm randomized clinical trial conducted from June 2019 through August 2023. SETTING: Four clinical trial sites in North Carolina, Texas, and Pennsylvania. PARTICIPANTS: Total of 1968 (90.4% of 2176) community-living PLWD with complete Medicare data. INTERVENTIONS: Health-system dementia care (HSDC) co-management by advance practice providers, community-based dementia care (CBDC) provided telephonically by a social worker, nurse, or licensed therapist, and usual care (UC), each lasting up to 18 months. MAIN OUTCOME: The number of DSAH was calculated as 546 (i.e., 18 months) minus the number of overnight days in a health care facility and days not alive, using data from Medicare. RESULTS: The percentages of DSAH were 83.5, 84.9, and 83.6 for the HSDC, CBDC, and UC groups, respectively. For each pairwise comparison among the three groups, incidence rate ratios for DSAH approximated 1.0, denoting no differences, and the corresponding mean differences in DSAH were small and not statistically significant: -7.2 (98.3% CI: -31.4 to 17.0) for HSDC versus CBDC; -0.3 (-48.4 to 47.7) for HSDC versus UC; and 6.9 (-41.3 to 55.5) for CBDC versus UC. There were no substantive differences in mean values across the three groups for days in any of the health care facilities. Mean [SD] days not alive were greatest for UC (68.3 [134.4]), followed by HSDC (65.3 [133.3]) and CBDC (60.0 [129.8]). CONCLUSIONS: In this pragmatic randomized clinical trial of dementia care programs, health system-based and community-based interventions did not differ from each other or from usual care in the number of DSAH for PLWD over the 18-month intervention period. TRIAL REGISTRATION: Clinicaltrials.gov identifier: NCT03786471.

Authors

Institutions

Publication Details

Journal
Journal of the American Geriatrics Society
Published
2026-11-17
DOI
https://doi.org/10.1111/jgs.70838
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Comparison of Two Dementia Care Interventions and Usual Care on Days Spent at Home: The D‐ CARE Randomized Clinical Trial

Katy L. B. Araujo, Maya L. Lichtenstein, Rebecca V. Galloway, David B. Reuben et al.
Journal of the American Geriatrics Society
Dementia and Cognitive Impairment Research
article

Comparison of Two Dementia Care Interventions and Usual Care on Days Spent at Home: The D‐ CARE Randomized Clinical Trial

Katy L. B. Araujo, Maya L. Lichtenstein, Rebecca V. Galloway, David B. Reuben, Elena Volpi, Thomas M. Gill, Peter N. Peduzzi, Jodi Liu, Alan B. Stevens, Jeff D. Williamson, Jenny Summapund, Mia Yang, Lee A. Jennings, Erich J. Greene, Yunshan Xu
article en

Abstract

BACKGROUND: Days spent at home (DSAH) is a clinically meaningful patient-centered outcome among persons living with dementia (PLWD). OBJECTIVE: To evaluate whether either of two dementia care interventions increased the number of DSAH compared with each other and with usual care. DESIGN: Pragmatic 18-month 3-arm randomized clinical trial conducted from June 2019 through August 2023. SETTING: Four clinical trial sites in North Carolina, Texas, and Pennsylvania. PARTICIPANTS: Total of 1968 (90.4% of 2176) community-living PLWD with complete Medicare data. INTERVENTIONS: Health-system dementia care (HSDC) co-management by advance practice providers, community-based dementia care (CBDC) provided telephonically by a social worker, nurse, or licensed therapist, and usual care (UC), each lasting up to 18 months. MAIN OUTCOME: The number of DSAH was calculated as 546 (i.e., 18 months) minus the number of overnight days in a health care facility and days not alive, using data from Medicare. RESULTS: The percentages of DSAH were 83.5, 84.9, and 83.6 for the HSDC, CBDC, and UC groups, respectively. For each pairwise comparison among the three groups, incidence rate ratios for DSAH approximated 1.0, denoting no differences, and the corresponding mean differences in DSAH were small and not statistically significant: -7.2 (98.3% CI: -31.4 to 17.0) for HSDC versus CBDC; -0.3 (-48.4 to 47.7) for HSDC versus UC; and 6.9 (-41.3 to 55.5) for CBDC versus UC. There were no substantive differences in mean values across the three groups for days in any of the health care facilities. Mean [SD] days not alive were greatest for UC (68.3 [134.4]), followed by HSDC (65.3 [133.3]) and CBDC (60.0 [129.8]). CONCLUSIONS: In this pragmatic randomized clinical trial of dementia care programs, health system-based and community-based interventions did not differ from each other or from usual care in the number of DSAH for PLWD over the 18-month intervention period. TRIAL REGISTRATION: Clinicaltrials.gov identifier: NCT03786471.

Journal of the American Geriatrics Society
University of Southern California (US), Atrium Health Wake Forest Baptist (US), University of California, Los Angeles (US), Yale University (US), Geisinger Wyoming Valley Medical Center (US), Baylor Scott & White Health (US), University of Oklahoma Health Sciences Center (US), Geisinger Health System (US), The University of Texas Medical Branch at Galveston (US)
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon